e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Biological markers in diagnosis, monitoring and treatment of respiratory disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of sputum eosinophil levels in the assessment of asthma treatment
E. Bacci, A. Di Paco, M. L. Bartoli, E. Garbella, M. Taccola, B. Vagaggini, M. Zingoni, M. De Santis, P. L. Paggiaro (Pisa, Italy)
Source:
Annual Congress 2004 - Biological markers in diagnosis, monitoring and treatment of respiratory disorders
Session:
Biological markers in diagnosis, monitoring and treatment of respiratory disorders
Session type:
Thematic Poster Session
Number:
3558
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Bacci, A. Di Paco, M. L. Bartoli, E. Garbella, M. Taccola, B. Vagaggini, M. Zingoni, M. De Santis, P. L. Paggiaro (Pisa, Italy). Role of sputum eosinophil levels in the assessment of asthma treatment. Eur Respir J 2004; 24: Suppl. 48, 3558
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Stability of sputum and blood eosinophil levels in COPD
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020
High sputum ECP levels detect functional impairment in asthma better than sputum eosinophils
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Comparison of N
ε
-(carboxymethyl)lysine levels and percentage of eosinophils in induced sputum for assessment of small airway involvements in asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Monitoring of sputum eosinophils in long-term treatment of bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 111s
Year: 2002
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations
Source: Eur Respir J 2006; 27: 483-494
Year: 2006
A study on the relevance of eosinophil counts in induced sputum and FENO and lung functions in asthmatics
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Role of blood neutrophilia as a biomarker in asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018
Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
The value of the serum ECP (eosinophil cationic protein) level for monitoring the treatment of allergic bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 268s
Year: 2001
The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Correlation between nasal secretion eosinophilia and induced sputum eosiniphilia in pediatric asthma
Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood
Year: 2010
Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002
An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity?
Source: Eur Respir J 2001; 18: Suppl. 33, 247s
Year: 2001
Bacterial exacerbation of COPD: assessment of neutrophil activation in induced sputum
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004
The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002
Sputum eosinophil percentages during a moderate exacerbation of asthma and during a natural cold
Source: Eur Respir J 2002; 20: Suppl. 38, 508s
Year: 2002
Mechanisms of noneosinophilic asthma
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
Impact on steroid dosing after introducing sputum eosinophils count into a severe asthma clinic
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Sputum eosinophilia vs exhaled NO as markers of airways inflammation in asthma: relationship with asthma control
Source: Eur Respir J 2005; 26: Suppl. 49, 736s
Year: 2005
Reduced eosinophil apoptosis in induced sputum correlates with asthma severity
Source: Eur Respir J 2003; 22: 484-490
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept